Amgen, Amerisource sued over drug kickback scheme
(Reuters)
Unusual Little Blurbs
Reuters - Biotechnology giant Amgen Inc and drug wholesaler AmerisourceBergen Corp were sued on Friday by 14 U.S. states and the District of Columbia over an alleged kickback scheme designed to boost sales of Amgen's popular anemia drug, Aranesp.
Source: Yahoo! News: Biotechnology News
Amgen sells $6bn of debt to buy back stock
Biotech group follows trend to boost share prices on a busy day for US corporate debt issuance
Source: FT.com - Pharmaceuticals